Article Versions Notes

Capelli I, Ribichini D, Provenzano M, Vetrano D, Aiello V, Cianciolo G, Vicennati V, Tomassetti A, Moschione G, Berti S, et al. Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease. Life. 2023; 13(4):1061. https://doi.org/10.3390/life13041061

Capelli, Irene, Danilo Ribichini, Michele Provenzano, Daniele Vetrano, Valeria Aiello, Giuseppe Cianciolo, Valentina Vicennati, Alessandro Tomassetti, Ginevra Moschione, Sabrina Berti, and et al. 2023. "Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease" Life 13, no. 4: 1061. https://doi.org/10.3390/life13041061

Capelli, I., Ribichini, D., Provenzano, M., Vetrano, D., Aiello, V., Cianciolo, G., Vicennati, V., Tomassetti, A., Moschione, G., Berti, S., Pagotto, U., & La Manna, G. (2023). Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease. Life, 13(4), 1061. https://doi.org/10.3390/life13041061